inhaled glutathione and emphysema reearch

inhaled glutathione and emphysema reearch Progress in the mechanism targeted drug therapy for COPD Antioxidants and Chronic Obstructive Pulmonary

Name: inhaled glutathione and emphysema reearch Progress in the mechanism targeted drug therapy for COPD Antioxidants and Chronic Obstructive Pulmonary
Brand: eiffelbuilders.com
SKU: 63860690212
Price: 23.97 USD
Availability: InStock
Rating: 4.7533 (28 reviews)

Antioxidants and Chronic Obstructive Pulmonary Disease > Journal of the COPD Foundation A next generation system for smoke inhalation integrated with a breathing lung on chip to model human lung responses to cigarette exposure Scientific Reports Molecular Approaches to Treating Chronic Obstructive Pulmonary Disease: Current Perspectives and Future Directions Advances in Inhaled Nanoparticle Drug Delivery for Pulmonary Disease Management PMC New treatments for copd Nature Reviews Drug Discovery Advancing chronic obstructive pulmonary disease treatment with inhaled nano carrier systems ScienceDirect

SKU: 63860690212 · From eiffelbuilders.com

4.8

USD23.97 USD50.97

Pay in 4 interest-free payments of $5.99 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Jul 31 - Aug 5

Description

Grade C evidence consists of case reports, animal model studies, and in vitro investigations providing preliminary but limited human relevance (83)

2.5.2 MicroRNA involvement MicroRNAs (miRNAs) are small non-coding RNAs that post-transcriptionally silence target mRNAs

Sci Rep 12:10856 Okada Y, Okada N, Makino S-i, Asakura H, Yamamoto S, Igimi S (2006) The sigma factor RpoN (r54) is involved in osmotolerance in Listeria monocytogenes

In lung adenocarcinoma models, disrupting lactate export homeostasis through MCT4 inhibition induces metabolic stress, thereby enhancing radiotherapy efficacy (99)